Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL

International Journal of Urology

Volumn 15, Issue 7, 2008, Pages 598-603

  Kawamura, Koji ^a   Suzuki, Hiroyoshi ^a   Kamiya, Naoto ^a   Imamoto, Takashi ^a   Yano, Masashi ^a   Miura, Junichiro ^a   Shimbo, Masaki ^b   Suzuki, Noriyuki ^b   Nakatsu, Hiroomi ^b   Ichikawa, Tomohiko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b ASAHI GENERAL HOSPITAL   (Japan)

Author keywords

Japanese population; Nomogram; Prostate biopsy; Prostate cancer; PSA < 10 ng mL

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONFIDENCE INTERVAL; DATA ANALYSIS; DECISION MAKING; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; ORGAN SIZE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; VALIDATION STUDY;

AGED; BIOPSY, NEEDLE; HUMANS; JAPAN; MALE; MIDDLE AGED; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 47249112169     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02058.x     Document Type: Article

References (28)

1. Shibata A, Ma J, Whittemore AS. Prostate cancer incidence and mortality in the United States and the United Kingdom. J. Natl. Cancer Inst. 1998 90 : 1230 1.
2. Bartsch G, Horninger W, Klocker H et al. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 2001 58 : 417 24.
3. Bill-Axelson A, Holmberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N. Engl. J. Med. 2005 352 : 1977 84.
4. Kamoi K, Babaian RJ. Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer. Semin. Oncol. 1999 26 : 140 9.
5. Catalona WJ, Partin AW, Slawin KM et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998 279 : 1542 7.
6. Suzuki H, Akakura K, Igarashi T et al. Clinical usefulness of serum anti-p53 antibodies for prostate cancer detection: a comparative study with PSA parameters. J. Urol. 2004 171 : 182 6.
7. Carlson GD, Calvanese CB, Partin AW. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. Urology 1998 52 : 455 61.
8. Eastham JA, May R, Robertson JL, Sartor O, Kattan MW. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate- specific antigen between 0 and 4 ng/mL. Urology 1999 54 : 709 13.
9. Potter SR, Horniger W, Tinzl M, Bartsch G, Partin AW. Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology 2001 57 : 1100 4.
10. Ohori M, Swindle P. Nomograms and instruments for the initial prostate evaluation: the ability to estimate the likelihood of identifying prostate cancer. Semin Urol. Oncol. 2002 20 : 116 22.
11. Djavan B, Remzi M, Zlotta A, Seitz C, Snow P, Marberger M. Novel artificial neural network for early detection of prostate cancer. J. Clin. Oncol. 2002 20 : 921 9.
12. Garzotto M, Hudson RG, Peters L et al. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen <10 ng/mL. Cancer 2003 98 : 1417 22.
13. Yanke BV, Carver BS, Bianco FJ et al. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. BJU Int. 2006 98 (4 783 7.
14. Nam RK, Toi A, Klotz LH et al. Assessing individual risk for prostate cancer. J. Clin. Oncol. 2007 25 : 3582 8.
15. Cook LS, Goldoft M, Schwartz SM et al. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J. Urol. 1999 161 : 152 5.
16. Suzuki H, Komiya A, Kamiya N et al. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology 2006 67 : 131 6.
17. Karakiewicz PI, Benayoun S, Kattan MW et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J. Urol. 2005 173 : 1930 4.
18. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J. Natl. Cancer Inst. 1998 90 : 766 71.
19. Chun FK, Graefen M, Briganti A et al. Initial biopsy outcome prediction - head-to-head comparison of a logistic regression based nomogram versus artificial neural network. Eur. Urol. 2007 51 : 1236 43.
20. Kawakami S, Numao N, Okubo Y et al. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur. Urol. 2008 (Epub ahead of print).
21. Babaian RJ, Dinney CP, Ramirez EI et al. Diagnostic testing for prostate cancer detection: less is best. Urology 1993 41 : 421 5.
22. Presti JC Jr, O'Dowd GJ, Miller MC, Mattu R, Veltri RW. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J. Urol. 2003 169 : 125 9.
23. Emiliozzi P, Scarpone P, DePaula F et al. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy. J. Urol. 2004 171 : 197 9.
24. Inahara M, Suzuki H, Kojima S et al. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectum examination. Urology 2006 68 : 815 9.
25. Chun FK, Briganti A, Graefen M et al. Development and external validation of an extended 10-core biopsy nomogram. Eur. Urol. 2007 52 : 436 44.
26. Chun FK, Briganti A, Graefen M et al. Development and external validation of an extended repeat biopsy nomogram. J. Urol. 2007 177 : 510 5.
27. Remzi M, Djavan B, Wammack R et al. Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy? Urology 2003 61 : 161 6.
28. Remti M, Fong YK, Dobrovits M et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J. Urol. 2005 174 : 1256 61.